Despite its potential, several challenges must be addressed for widespread clinical adoption:
Safety and Toxicity: Understanding the safety profile of nanoparticles is crucial. Clinicians need reliable data on the long-term effects of these materials on human health. Regulatory Hurdles: The regulatory landscape for nanotechnology in medicine is still evolving. Clinicians must navigate complex approval processes to bring nanotechnology-based treatments to patients. Cost and Accessibility: The high cost of developing and producing nanotechnology-based solutions may limit their accessibility. Clinicians must advocate for cost-effective solutions to benefit a broader patient population.
